Last Chance for Children is Proud to Announce its Partnership with Generex Biotechnology & NuGenerex Immuno-Oncology to SAFELY and EFFECTIVELY Vaccinate Children and Pregnant Women

NEXT STORY
Merit Medical to Present at 20th Annual Needham Healthcare Conference
PREV STORY
Viral Vector & Plasmid DNA Manufacturing Market Research Report by Type, by Indication, by Workflow, by Application, by End User – United States Forecast to 2025 – Cumulative Impact of COVID-19
Subscribe to PM360
Follow Us

Experts on Call

Get in touch with PM360 Experts On Call

Ads

You May Also Like

Helix BioPharma Corp. Extends Annual Meeting Date

RICHMOND HILL, Ontario, Jan. 28, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX, FSE: ...

author_avatar
NASDAQ Market News

OPKO Health Submits Premarket Approval Application with FDA for a Point-of-Care PSA Test with the Claros® 1 Platform

MIAMI, Nov. 07, 2017 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ:OPK) ("OPKO" or "the ...

author_avatar
NASDAQ Market News

Chembio Diagnostics Reports First Quarter 2018 Financial Results

MEDFORD, N.Y., May 09, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader ...

author_avatar
NASDAQ Market News